Infant deaths from critical congenital heart disease (CCHD) decreased more than 33 percent in eight states that mandated screening for CCHD using a test called pulse oximetry. In addition, deaths from other or unspecified cardiac causes decreased by 21 percent, according to a recent study.

Fujifilm Medical Systems U.S.A. Inc. announced the expansion of the company's artificial intelligence (AI) development initiative with entry in the U.S. market. The AI development initiative will harness the power of AI to enhance Fujifilm’s imaging and informatics healthcare Synapse portfolio which includes Synapse PACS (picture archiving and communication system), Synapse Cardiovascular and Synapse VNA (vendor neutral archive), among other solutions. The initiative was on display at the 2017 Radiological Society of North America (RSNA) annual meeting, Nov. 26-Dec. 1 in Chicago.

Philips recently announced the results of a comprehensive, independent, two-year study demonstrating the clinical workflow benefits of its next-generation image-guided therapy platform, Azurion. The study investigated nearly 800 patient procedures to evaluate the impact of Azurion at St. Antonius Hospital in Nieuwegein, the Netherlands. The data demonstrated clinicians’ use of Azurion resulted in significant time savings for the hospital, including a 17 percent reduction of the average interventional procedure time, a 12 percent reduction of in-lab patient preparation time, and a 28 percent reduction of post-procedure lab time.

November 25, 2017 — Children and young adults with diabetes may be seven times more likely to die from sudden cardiac ...

November 25, 2017 — The majority of patients without health insurance who were hospitalized for heart attack, stroke or ...

November 25, 2017 — Treatment for gum disease, or periodontitis, significantly lowered blood pressure among Chinese ...